Healthcare >> Analyst Interviews >> January 17, 2000

Brain & Spine: Drugs And Devices : Andrew T. Jay – First Union Securities

ANDREW T. JAY follows medical technology at First Union Securities. He has been a sell-side analyst on Wall Street for six years and is widely known for his work with emerging growth companies such as Perclose, Target Therapeutics and Wesley Jessen. His previous work experience includes three years of management consulting with a major firm and five years running a sizable dental practice. Dr. Jay holds an M.B.A. from Northwestern's Kellogg School and a D.M.D. from the University of Pennsylvania. He completed his Bachelor of Science degree at Rensselaer Polytechnic Institute in two years. Dr. Jay serves on the Board of Directors at the Epilepsy Foundation of Massachusetts and Rhode Island. Profile
TWST: Tell us about the First Union Brain and Spine Symposium and the

range of companies that will be attending the conference.

Dr. Jay: We're excited about this conference because it's the